Загрузка...
Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes
BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are reported to have BP-lowering effect in addition to blood glucose-lowering effect, however, its mechanism is still unknown. This study aimed to investigate the mechanism of blood pressure (BP) lowering effects of SGLT2 inhibitors using...
Сохранить в:
| Опубликовано в: : | BMC Pharmacol Toxicol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385592/ https://ncbi.nlm.nih.gov/pubmed/28391776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-017-0125-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|